GE

Genomictree Inc.

A molecular diagnostics company developing tests for the early detection of cancer.

228760 | KO

Overview

Corporate Details

ISIN(s):
KR7228760005
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노10로 44-6, 대전광역시

Description

Genomictree Inc. is a molecular diagnostics company that develops and commercializes products for the early detection and diagnosis of cancer. The company specializes in epigenomics, utilizing its proprietary genomic-scale discovery tools to identify DNA methylation biomarkers. Its flagship product line, EarlyTect®, offers non-invasive tests for the early screening of colorectal, lung, and bladder cancers. Additionally, Genomictree provides AccuraTect™, a companion diagnostic test for cancer. The company's mission is to improve patient quality of life and reduce medical costs through accessible and accurate early-stage cancer detection.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2020-03-06 00:00
주주총회소집결의
Korean 14.1 KB
2020-03-02 00:00
투자판단관련주요경영사항(폐암 조기진단 보조용 체외분자진단제품 (EarlyTect Lung Cancer) 판매를 위한 의료기기 제조허가 신청)
Korean 9.8 KB
2020-02-24 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 13.8 KB
2020-01-20 00:00
기타주요경영사항(종속회사의주요경영사항)
Korean 10.0 KB
2020-01-09 00:00
유상증자결정(종속회사의주요경영사항)
Korean 22.0 KB
2020-01-09 00:00
[첨부추가]타법인주식및출자증권취득결정
Korean 29.5 KB
2020-01-02 00:00
투자판단관련주요경영사항(폐암 진단용 종양관련유전자검사시약(GT-LC-1)의 확증임상시험 결과 공지)
Korean 7.6 KB
2019-12-12 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.4 KB
2019-12-12 00:00
기타경영사항(자율공시)(KRAS 7종 돌연변이 진단제품(AccuraDtect-KRAS) 3등급 체외진단용 의료기기 제조허가 승인)
Korean 5.8 KB
2019-11-14 00:00
분기보고서 (2019.09)
Korean 1.2 MB
2019-11-13 00:00
기업설명회(IR)개최
Korean 7.3 KB
2019-11-13 00:00
기업설명회(IR)개최
Korean 7.2 KB
2019-10-30 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.1 KB
2019-08-14 00:00
기타주요경영사항
Korean 6.8 KB
2019-08-14 00:00
반기보고서 (2019.06)
Korean 995.0 KB

Automate Your Workflow. Get a real-time feed of all Genomictree Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Genomictree Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Genomictree Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.